Literature DB >> 29159404

Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression.

Nina R Joyce1,2, Megan S Schuler3, Scott E Hadland4,5, Laura A Hatfield1.   

Abstract

Importance: Depression during childhood and adolescence is heterogeneous. Treatment patterns are often examined in aggregate, yet there is substantial variability across individual treatment trajectories. Understanding this variability can help identify treatment gaps among youths with depression. Objective: To characterize heterogeneity in 12-month trajectories of psychotherapy and antidepressant treatment in youths with depression. Design, Setting, and Participants: This is a longitudinal-cohort study of youths 18 years or younger with a new diagnosis of depression and at least 12 months of follow-up following diagnosis, as determined from commercial insurance claims filed from 2007 to 2014. Latent class models were fit to summary measures of psychotherapy and antidepressant use in the 12 months following the index diagnosis. We examined variation in baseline health, health care utilization, and health outcomes across classes with similar patterns of psychotherapy and antidepressant use. Data analysis took place between June 2016 and March 2017. Main Outcomes and Measures: Psychotherapy and antidepressant use.
Results: The cohort included 84 909 individuals with a mean (SD) age at index diagnosis of 15.0 (2.6) years, of whom 49 995 (59%) were female. Attention-deficit/hyperactivity disorder (n = 14 625; 17%) and anxiety (n = 12 358; 15%) were the most common comorbid diagnoses. During the assessment period, 59 023 individuals (70%) received psychotherapy at any point, and 33 997 individuals (40%) were dispensed antidepressants at any point. Eight classes with distinct treatment trajectories were identified, which we classified into 4 broad groups: 3 classes that received dual therapy (n = 18 710; 22%), 2 classes that received antidepressant monotherapy (n = 15 287; 18%), 2 classes that received psychotherapy monotherapy (n = 40 313; 48%) and 1 class that received no treatment (n = 10 599; 13%). The most common class received psychotherapy monotherapy (n = 35 243; 42%) and had the lowest incidence of attempted suicide (0.8 per 100 person-years [PY]) and inpatient hospitalization (3.5 per 100 PY) during the assessment period and postassessment period (0.5 per 100 PY and 1.3 per 100 PY, respectively). The group receiving dual therapy had the highest incidence of attempted suicide during the assessment period (4.7-7.1 per 100 PY, depending on the class) and postassessment period (1.5-1.7 per 100 PY). Conclusions and Relevance: In our sample, 13% of youths received no treatment, and 18% received antidepressants without concomitant psychotherapy. Summary measures of treatment can mask informative patterns of psychotherapy and antidepressant use. Latent class analysis can be used to identify subgroups of individuals with similar treatment trajectories and help identify treatment gaps under current practice patterns.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29159404      PMCID: PMC5833520          DOI: 10.1001/jamapediatrics.2017.3808

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  26 in total

1.  Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.

Authors:  Robert D Gibbons; Marcelo Coca Perraillon; Kwan Hur; Rena M Conti; Robert J Valuck; David A Brent
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-09-29       Impact factor: 2.890

2.  Data-driven course trajectories in primary care patients with major depressive disorder.

Authors:  Klaas J Wardenaar; Henk-Jan Conradi; Peter de Jonge
Journal:  Depress Anxiety       Date:  2014-01-03       Impact factor: 6.505

3.  Antidepressants and suicide attempts in children.

Authors:  William O Cooper; S Todd Callahan; Ayumi Shintani; D Catherine Fuchs; Richard C Shelton; Judith A Dudley; Amy J Graves; Wayne A Ray
Journal:  Pediatrics       Date:  2014-01-06       Impact factor: 7.124

4.  Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment.

Authors:  Shelli Avenevoli; Joel Swendsen; Jian-Ping He; Marcy Burstein; Kathleen Ries Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-10-29       Impact factor: 8.829

5.  Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

Authors:  Robert J Valuck; Anne M Libby; Marion R Sills; Alexis A Giese; Richard R Allen
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  The relationship between antidepressant prescription rates and rate of early adolescent suicide.

Authors:  Robert D Gibbons; Kwan Hur; Dulal K Bhaumik; J John Mann
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

7.  National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults.

Authors:  Ramin Mojtabai; Mark Olfson; Beth Han
Journal:  Pediatrics       Date:  2016-11-14       Impact factor: 7.124

8.  Heterogeneity in 10-Year Course Trajectories of Moderate to Severe Major Depressive Disorder: A Danish National Register-Based Study.

Authors:  Katherine L Musliner; Trine Munk-Olsen; Thomas M Laursen; William W Eaton; Peter P Zandi; Preben B Mortensen
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

9.  Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.

Authors:  Boris Birmaher; David Brent; William Bernet; Oscar Bukstein; Heather Walter; R Scott Benson; Allan Chrisman; Tiffany Farchione; Laurence Greenhill; John Hamilton; Helene Keable; Joan Kinlan; Ulrich Schoettle; Saundra Stock; Kristin Kroeger Ptakowski; Jennifer Medicus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

10.  Suicide attempts among patients starting depression treatment with medications or psychotherapy.

Authors:  Gregory E Simon; James Savarino
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

View more
  2 in total

1.  Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies.

Authors:  Kuan Li; Guibao Zhou; Yan Xiao; Jiayu Gu; Qiuling Chen; Shouxia Xie; Junyan Wu
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

2.  Associations between depression subtype and functional impairment and treatment utilization in a national sample of adolescents.

Authors:  Megan S Schuler; Stephen E Gilman; Rachel M Burns; Elizabeth Roth; Joshua Breslau
Journal:  J Affect Disord       Date:  2021-03-11       Impact factor: 4.839

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.